Chronic Myelogenous Leukemia

Filter By:
Der münchner Patienten Vertreter Jan Geissler, nahm an CML Aufklärungssitz​ungen eines Experten-Treffe​ns in New Orleans teil. Er hat folgendes zu berichten.
by:patientpower | 153 views
Antibody-drug conjugates or ADCs represent an innovative therapeutic application that combines the unique properties of monoclonal antibodies (mAbs) with the potent cell killing activity of cytotoxic small molecule drugs. The key components of antibody-drug conjugates include a monoclonal antibody (mAbs), a stable linkers and a cytotoxic (anti...
by:ADCReview | 749 views
While targeted drug therapies have proven effective for most patients diagnosed with Chronic Myelogenous Leukemia (CML), some patients encounter clinical issues that cause them to lose their response to treatment. What happens then? CML expert Dr. Michael Mauro addresses the question, and shares the...
by:patientpower | 2236 views
With an annual $100,000+ cost for current treatment options, physicians treating Chronic Myelogenous Leukemia (CML) patients have raised questions about whether these price levels are sustainable. In a recent article in "Blood," the journal of the American Society of Hematology, 100+ physi...
by:patientpower | 2308 views
Jeffrey Lipton discusses news from ASCO 2012 about how Tasigna could bring faster and deeper responses, taking some newly diagnosed patients all the way to Complete Molecular Response (CMR) well within the first year of therapy. Dr. Lipton explains that the focus in Chronic Myelogenous Leukemia (CML...
by:patientpower | 1235 views
A promising new treatment brings hope for patients with a rare form of leukemia who have run out of treatment options. Results reported for a third-line treatment for Chronic Myelogenous Leukemia (CML) show the investigational drug, ponatinib, helped patients with relapsed or resistant response to p...
by:patientpower | 1171 views
Imagine having routine pre-surgery blood work then being told you have Chronic Myelogenous Leukemia (CML). Your whole world is quickly turned upside down. This surreal experience happened to Erin Havel 5 years ago. In this program, Erin and her hematologist/on​cologist Dr. Michael Milder, from the Sw...
by:patientpower | 923 views
Being diagnosed with any chronic condition can be challenging. Being diagnosed with cancer can be terrifying. To help manage a condition like Chronic Myelogenous Leukemia (CML), it is critical to have a close relationship with a doctor you respect and trust. Joining us is Sandra Stagg, diagnosed with CML 5 years ago, and her oncologist, Dr. Jessica...
by:patientpower | 969 views
Medical oncologist Alexander Lesokhin discusses a phase I clinical trial assessing anti-PD-1 immunotherapy in patients with relapsed or refractory hematologic cancers [http://www.m...)]. These drugs are designed to boost the body's immune system against cancer by target...
by:mskcc | 2158 views
Dr. Pierre Laneuville is an Associate Professor (GFT-U) in the Department of Medicine and Oncology at McGill University and the former Head of Hematology for the McGill University Health Center talks about the treatment of lymphoma using Bendamustine. Dr. Laneuville obtained an Honours B.Sc. at McMaster University, his medical degree at the Univ...
by:feeds | 1679 views

Top Tags

Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Different type of MD 
Other oncology Professional 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.

username:   password: remember me

Sign In

Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)